¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Golgi's mixed method"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • mixed order reaction
    È¥ÇÕ¼ø¼­¹ÝÀÀ
  • mixed pineocytoma
    È¥ÇÕ¼Ö¹æ¿ï»ùÁ¾, È¥ÇÕ¼Û°úüÁ¾
  • mixed psychosis
    È¥ÇÕÁ¤½Åº´
  • mixed tumor
    È¥ÇÕÁ¾¾ç
  • mixed vaccine
    È¥ÇÕ¹é½Å
  • ascending method
    ¿Ã¸²¹ý, »ó½Â¹ý
  • aspirative irrigation method
    ÈíÀμ¼Ã´¹ý
  • auscultatory method
    ûÁø¹ý
  • acquisition method
    ȹµæ¹æ¹ý
  • activated sludge method
    Ȱ¼ºÇذ¨¸ð·¡¹ý, Ȱ¼º¿À´Ï¹ý
  • actuarial method
    º¸ÇèÅë°è¹ý
  • agar diffusion method
    ¿ì¹«È®»ê¹ý
  • alkali denaturation method
    ¾ËÄ®¸®º¯¼º¹ý
  • allochromatic method
    º¯»ö¹ý
  • alternate paired case method
    ±³´ë´ë¸³È¯ÀÚ¿ä¹ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • mixed tumor
    È¥ÇÕÁ¾¾ç
  • mixed vaccine
    È¥ÇÕ¹é½Å
  • mixed germ cell tumor
    È¥ÇÕ¹è¾Æ¼¼Æ÷Á¾¾ç
  • mixed lymphocyte reaction
    ¸²ÇÁ±¸È¥ÇÕ¹è¾ç¹ÝÀÀ
  • mixed lymphocyte culture test
    È¥ÇÕ¸²ÇÁ±¸¹è¾ç°Ë»ç
  • mixed order reaction
    È¥ÇÕÂ÷¹ÝÀÀ
  • mixed suspended solid
    È¥ÇÕºÎÀ¯°íÇü¹°
  • acquisition method
    ȹµæ¹æ¹ý
  • activated sludge method
    Ȱ¼ºÇذ¨¸ð·¡¹ý, Ȱ¼º¿À´Ï¹ý
  • actuarial method
    º¸ÇèÅë°è¹ý
  • agar diffusion method
    ¿ì¹«È®»ê¹ý
  • agar filtration method
    ¿ì¹«°Å¸£±â¹ý, ¿ì¹«¿©°ú¹ý
  • agar layer method
    ¿ì¹«ÁßÃþ¹ý
  • agar streak method
    ¿ì¹«È­¼±¹ý
  • alkali denaturation method
    ¾ËÄ®¸®º¯¼º¹ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Cathelins method
    Ä«ÅÚ¶õ¹ý.
  • Chandlers method
    Âùµé·¯¹ý.
  • Chaputs method
    »þǪ¹ý.
  • Cherry method
    ü¸®¹æ¹ý
  • Chopper method Chopper
    ¹ý
  • Clinistix method
    Ŭ¸®´Ï½ºÆ½½º(¹æ)¹ý
  • Clinitest method
    Ŭ¸®´ÏÅ×½ºÆ®(¹æ)¹ý
  • Crede method of expressing placenta
    Å©·¹µ¥ ŹݾÐÃà¹ý.
  • Halsteds method (operation)
    Ȧ½ºÅ×µå ¼ö¼ú.
  • Hegar s method =H s operation
    Çì°¡¼ö ¼ú.
  • India ink method
    ¸Ô¹°°æ°Ë¹ý
  • Indian ink method
    ¸Ô¹°µµ¸»¹ý
  • Kay-Bodansky method
    Ä«ÀÌ-º¸´Ü½ºÅ°¹ý
  • King-Armstrong method
    Å·-¾Ï½ºÆ®·Õ¹ý
  • Lod score method
    ·ÎµåÁ¡¼ö¹ý
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • mixed cellular cast
    È¥ÇÕ¼¼Æ÷¿øÁÖ
  • mixed chancre
    È¥ÇÕ¼º Çϰ¨
  • mixed color
    È¥ÇÕ»ö(ûèùêßä).
  • mixed connective tissue disease
    È¥ÇÕ °áÇÕÁ¶Á÷º´
  • mixed connective tissue disease
    È¥ÇÕ¼º °áüÁ¶Á÷ Áúȯ(¡­ Ì¿ô÷ðÚòÄ òðü´)
  • mixed connective tissue disease
    È¥ÇÕ°áüÁ¶Á÷Áúȯ
  • mixed connective tissue disease(MCTD)
  • mixed cryoglobulin syndrome
    È¥ÇÕÇѳñ۷κҸ°ÁõÈıº
  • mixed cryoglobulinemia
    È¥ÇÕ ÇÑ·© ±Û·ÎºÒ¸°Ç÷Áõ
  • mixed cryoglobulinemia
    È¥ÇÕ¼º ÇÑ·©±Û·ÎºÒ¸°Ç÷Áõ(¡­ ùÎÕÒ¡­úìñø)
  • mixed crystal
    È¥Á¤(ûèïÜ).
  • mixed culture
    È¥ÇÕ¹è¾ç(ûèùêÛÆå×).
  • mixed deafness
    È¥ÇÕ¼º ³­Ã»(̴̰ËÛ˻̧).
  • mixed deafness
    È¥ÇÕ(¼º) ³­Ã»
  • mixed decimal
    ´ë¼Ò¼ö(Óáá³â¦).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • chain terminator method
    »ç½½Çü¼º(û¡à÷) Á¾·áÀÚ¹ý(ðûÖõí­Ûö)
  • channels ratio method
    ä³Î ºñÀ²¹ý(Ýï×ËÛö)
  • chronometric method
    ½Ã°£ ÃøÁ¤¹ý(ãÁÊàö´ïÒÛö)
  • Coon's method
    Äï ¹ý(Ûö) (ÔÒ) indirect fluorescent antibody technique
  • crossover method
    ±³Â÷¹ý(Îßó©Ûö)
  • cryoscopic method
    ºùÁ¡ÃøÁ¤¹ý(Þ¼ïÇö´ïÒÛö)
  • Dean and Webb method
    µò°ú¿þºê ¹ý(Ûö)
  • deletion method
    °á¼Õ¹ý(ÌÀáßÛö)
  • differential method
    °¨º°¹ý(ÊüܬÛö)
  • DNAase protection method
    DNAase º¸È£¹ý(ÜÁûÞÛö)
  • double-label method
    ÀÌÁß Ç¥Áö¹ý(ì£ñìøöò½Ûö) (ÔÒ) handle method
  • end-point method
    Á¾¸»Á¡¹ý(ðûØÇïÇÛö)
  • Fiske-SubbaRow method
    ÇǽºÄÉ-»ç¹Ù·Î¿ì ¹ý(Ûö)
  • flow method
    È긲¹ý(Ûö)
  • flux ratio method
    Çöô½º ºñÀ²¹ý(Ýï×ËÛö)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
LTH Low Temperature Holding Method of Pasteurization; Àú¿ÂÀ¯Áö½Ä»ì±Õ¹ý(¿ìÀ¯¼Òµ¶¹ý)
  ; 62 - 63 ¡É, 30 mi...
ARM adrenergic receptor material; aerosol rebreathing method; ambulatory renal monitor; anorectal manome...
BET benign epithelial tumor; bleeding esophageal varix; Brunauer-Emmet-Teller [method]
BLB Baker-Lima-Baker [mask]; Bessey-Lowry-Brock [method or unit]; black light bulb; Boothby-Lovelace-Bul...
BSAM basic sequential access method
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
LAM Lactational Amenorrhea Method
MEM Maximum Entropy Method
MDL method detection limit
D.C.C. dextran coated charcoal method
PAP peroxidase anti peroxidase method
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • alkaline phosphatase antialkaline phophatase method
    ¾ËÄ®¸®¼º Æ÷½ºÆÄŸÁ¦ Ç×¾ËÄ®¸®¼º Æ÷½ºÆÄŸÁ¦¹ý
  • aspirative-irrigation method
    È©ÀÎ ¼¼Ã´¹ý
  • Barber's method
    ¹Ù¾Æ¹ö ¹ý
    ¹Ì»ý¹°À» Çö¹Ì°æ¿¡¼­ ´Ü¸®ÇÏ´Â Á¶ÀÛ¹ý.
  • Barker's method
    ¹Ù¾ÆÄ¿¹ý
    Ƽ¿À½Ã¾È¿°°ú Á¦ 2Áú»ê öÀÇ È­ÇÕ¿¡ ÀÇÇÑ ºñ»ö¹ý.
  • bioassay method
    »ý¹°ÇÐÀû °ËÁ¤¹ý
  • candle jar method
    Ä­µé Àھƹý, Ä­µé ÀÚ¾Æ ¹è¾ç¹ý
  • carbol fuchsin method
    Ä«¸£º¼ Ǫũ½Å ¹ý
  • Charter's method
    Â÷ÅÍ ¹ý
    Ä©¼Ö »ç¿ë¹ýÀÇ Çϳª·Î, ¼ÖÀÌ Ä¡¾Æ¿Í Ä¡Àº¿¡ ´ëÇÏ¿© 45¡Æ·Î Ä¡°ü ÂÊÀ¸·Î ±â¿ï¾îÁö°Ô Çϸ鼭 ¼öÆòÀ» À¯Áö½ÃŰ°í ¼ÖÀÇ ¹ÝÀº Ä¡¾Æ¿¡ ±×¸®°í ¹ÝÀº Ä¡Àº¿¡ ÀÖµµ·Ï ÇÑ ´ÙÀ½, ¾ÆÁÖ ÀÛÀº ¿øÀ» ±×¸®´Â µíÇÑ Áøµ¿ ¿îµ¿À» Áָ鼭 ÇÏ´Â ¹æ¹ý. À½½Ä Â±â¿Í Ä¡°£¿¡ ¼ÖÀÌ µé¾î°¡°Ô µÇ¾î ¸¶»çÁö ¿ªÇÒµµ ÇÑ´Ù.
  • Chopper method
    Chopper ¹ý
  • column diffusion method
    ±âµÕ È®»ê ¹æ¹ý
  • combination method
    ¿¬ÇÕ¹ý
    Àη¹À̳ª Ä¡°ü º¸Ã¶ Á¦ÀÛ¿¡¼­ ¸ðÇü»ó¿¡ ³³ÇüÀ» ÀÏÂ÷·Î ¿Ï¼ºÇÏ¿© ±¸°­³»¿¡ ½ÃÀûÇÏ¿© ½Ã°øÇÏ°í ¸Å¸ôÇÏ¿© ÁÖÁ¶ÇÏ¿© ¾ò´Â °£Á¢¹ý°ú Á÷Á¢¹ýÀ» °â¿ëÇÏ´Â ¹æ¹ýÀÌ´Ù.
  • Dehn-Clark`s method
    µ§-Ŭ¶óÅ©¹ý
  • Denis-Leche's method
    µ¥´Ï½º-·¹Ä¡¹ý
    Àü Ȳȭ¹°ÀÇ °ËÃâ¹ýÀ¸·Î, »êÀ» °¡ÇØ ºÎÆÐÇÑ ´Ü¹éÁúÀ» Á¦°ÅÇÏ°í ¿°È­ ¹Ù·ý¿¡ ÀÇÇØ ħÀü °ÇÁ¶½ÃŲ ÈÄ Äª·®ÇÑ´Ù.
  • diffusion method
    È®»ê¹ý
  • direct method
    Á÷Á¢¹ý
    ȯÀÚÀÇ ±¸°­³»¿¡¼­ ¿Î½º Á¶°¢ÇÏ¿© ³³ ¿øÇüÀ» ¾ò¾î ¸Å¸ôÇϰí ÁÖÁ¶ÇÏ¿© Àη¹À̳ª Ä¡°ü º¸Ã¶¹°À» ¾ò´Â ¹æ¹ýÀÌ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
mixed connective tissue disease <syndrome> A syndrome with overlapping clinical features of systemic lupus erythematosus, scleroderma, polymyositis, and Raynaud's phenomenon.
The disease is differentially characterised by high serum titres of antibodies to ribonuclease-sensitive extractable (saline soluble) nuclear antigen (nuclear ribonucleoprotein) and a speckled epidermal nuclear staining pattern on direct immunofluorescence.
A more modern term for this condition is the undifferentiated connective tissues disease.
(22 Sep 2002)
mixed dentition <dentistry> The situation when both deciduous and permanent teeth are present.
(08 Jan 1998)
mixed discrete-continuous random variable <statistics> A random variable that may assume some values with probabilities and others with probability densities.
For example, in a 35-year-old man with familial polyposis of the colon, the distribution of time until malignant disease occurs consists of a probability that he already has cancer (which would be assigned the waiting time 0), a probability density of developing it in the future and a probability that he will die of some other cause before he develops cancer.
(05 Mar 2000)
mixed disulfide <chemistry> Disulfide which is not symmetric on both sides of the -s-s- linkage; e.g., the disulfide formed between coenzyme A and glutathione or between cysteine and coenzyme A or glutathione.
Synonym: asymmetric disulfide.
(05 Mar 2000)
mixed esotropia <ophthalmology> That type of esotropia in which both accommodative and nonaccommodative factors are present.
(05 Mar 2000)
mixed expired gas <physiology> One or more complete breaths of expired gas coming thoroughly mixed from the dead space and the alveoli.
(05 Mar 2000)
mixed function oxidases <enzyme> Catalyse the insertion of one oxygen atom of molecular oxygen into the organ substrate. Require a second substrate to donate electrons for the reduction of the second atom in the oxygen molecule to water.
Registry number: EC 1.13.12.
(12 Dec 1998)
mixed gland A gland that contains both serous and mucous secretory units, a gland that is both exocrine and endocrine, e.g., the pancreas.
(05 Mar 2000)
mixed glioma <tumour> A glioma comprised of two or more malignant elements, most frequently astrocytoma and oligodendroglioma.
(05 Mar 2000)
mixed hyperlipaemia Hyperlipoproteinaemia characterised by increased plasma levels of chylomicrons, VLDL, pre-beta-lipoproteins, and triglycerides, and slight rise of cholesterol on a normal diet, with beta-lipoproteins normal; may be accompanied by bouts of abdominal pain, hepatosplenomegaly, susceptibility to atherosclerosis, and abnormal glucose tolerance; probably autosomal recessive inheritance.
Synonym: combined fat-and carbohydrate-induced hyperlipaemia, familial hyperchylomicronaemia with hyperprebetalipoproteinaemia, mixed hyperlipaemia.
(05 Mar 2000)
mixed hyperlipidemia mixed hyperlipoproteinaemia familial, type 5 hyperlipidemia
mixed hyperlipoproteinaemia familial Type 5 hyperlipidemia, elevations of VLDL and chylomicrons found in plasma.
Synonym: mixed hyperlipidemia.
(05 Mar 2000)
mixed hypoglycaemia Hypoglycaemia due to more than one cause.
(05 Mar 2000)
mixed infection Infection by more than one variety of pathogenic microorganisms.
(05 Mar 2000)
mixed lymphocyte culture <investigation> Test to determine whether a patients and donor's white blood cells interact adversely. Often used to determine whether a person would be a suitable bone marrow donor for a particular patient.
(16 Dec 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • mixed market economy
    È¥ÇÕ ½ÃÀå °æÁ¦
  • mixed marriage
    (´Ù¸¥ Á¾Á·,Á¾±³°£ÀÇ) ÀâÈ¥
  • mixed media
    È¥ÇÕ ¸Åü;¿µ»ó;±×¸²;À½¾Ç µîÀÇ Á¾ÇÕÀû ¿¹¼ú Ç¥Çö
  • mixed metaphor
    È¥À¯
  • mixed number
    ´ëºÐ¼ö
  • mixed tithe
    (°¡Ãà·ù¿¡¼­ÀÇ ¼öÀÍ¿¡ ´ëÇÑ) 10ºÐÀÇ 1ÀÇ ¼¼
  • mixed train
    (°´Â÷¿Í È­Â÷ÀÇ) È¥¼º ¿­Â÷
  • ready-mixed
    ¹Ì¸® Á¶Á¦(Á¶ÇÕ,È¥ÇÕ)ÇÑ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á